Medtech
Six leadership editions
AI in MedTech
Your regulatory affairs director holds twelve months of market access in their head. When they leave, the submission stops. The question is whether that expertise is institutional or personal.
What's Changing in Your Capital Story
Your next €10M of capital. The device-sale number you sign. The thesis your board can recite back. Three questions that look separate, but are actually one. A briefing for CFOs at mid-market European medtech firms.
What's Changing in How You Get to Market
Your regulatory team is the rate-limiting constraint on revenue. Their knowledge lives in two or three people's heads. Your CE mark cycles are not compressing. Three operations problems that are actually one. A briefing for operations leaders at European medtech companies.
What's Changing in the Bench You're Building
Your senior RA director took a competitor call. Your senior biostatistician retires in eighteen months. Your 2030 bench is being shaped by decisions you were not invited to. A briefing for Chief Human Resources Officers at mid-market European medtech firms.
What's Changing on Your Tender Floor
The procurement committee runs structured evaluation. Your top KAM is sixty-one. Your head of market access is at a conference. A briefing for Commercial Directors at mid-market European medtech firms.
What's Changing in the Moat You Build
Your R&D budget is two instruments pretending to be one. Your device sits above a model layer that commoditises every eighteen months. Your scorecard measures submission-cycle time and engineering headcount, and neither is the 2026 question. A briefing for CTOs, CPOs, and Heads of R&D at mid-market European medtech firms.